Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vas Narasimhan
Vas Narasimhan
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
CNBC
Thu, 09/19/24 - 11:13 am
Novartis
Pharma CEOs
weight loss
obesity
Vas Narasimhan
‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO
Fierce Biotech
Thu, 07/18/24 - 11:13 pm
Novartis
Pharma CEOs
obesity
Vas Narasimhan
GLP-1 agonists
Novartis CEO sees IRA impact ‘manageable’ in short run, maintains midterm growth goal
Fierce Pharma
Thu, 07/18/24 - 11:02 pm
Novartis
Pharma CEOs
Vas Narasimhan
Inflation Reduction Act
Novartis CEO's 2023 pay rises 21% as Roche's helmsman nets $11M in his first year
Fierce Pharma
Mon, 02/5/24 - 11:16 pm
Novartis
Roche
Pharma CEOs
executive pay
Vas Narasimhan
Thomas Schinecker
After Novartis' radiotherapy Pluvicto disappoints, CEO touts 'compelling case' for future growth
Fierce Pharma
Wed, 01/31/24 - 11:38 am
Novartis
earnings
Pharma CEOs
Vas Narasimhan
Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter
Fierce Pharma
Wed, 03/8/23 - 09:51 am
Novartis
Pharma CEOs
Vas Narasimhan
executive pay
restructuring
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Fierce Pharma
Wed, 02/1/23 - 10:22 pm
Novartis
Vas Narasimhan
PhRMA
Inflation Reduction Act
PBMs
small molecule drugs
Novartis CEO says Covid likely to become endemic, urges investment in pandemic preparedness
CNBC
Fri, 01/20/23 - 10:32 am
Novartis
Pharma CEOs
Vas Narasimhan
COVID-19
pandemic
Public Health
What is Novartis without Sandoz? Vas Narasimhan is 'patient' as new company takes form
Endpoints
Tue, 10/25/22 - 11:13 pm
Novartis
Pharma CEOs
Vas Narasimhan
Vas Narasimhan and Severin Schwan each claimed pay packets worth $12M+ for 2021
Endpoints
Sat, 02/12/22 - 11:49 pm
Roche
Novartis
executive pay
Severin Schwan
Vas Narasimhan
No news anytime soon on Sandoz sale, says Novartis
Pharmaforum
Thu, 02/3/22 - 10:35 am
Novartis
Vas Narasimhan
Sandoz
generics
M&A
Now reimagining home, office schedules: Novartis CEO Vas Narasimhan sees a new normal in the post-Covid era
Endpoints
Tue, 04/27/21 - 10:56 am
Novartis
Vas Narasimhan
pandemic
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales
Fierce Pharma
Mon, 02/22/21 - 10:49 am
Novartis
executive pay
Vas Narasimhan
Pharma CEOs
pandemic
COVID-19
Novartis CEO: COVID-19 vaccine might take until end of 2021 to reach patients
Fierce Pharma
Fri, 05/15/20 - 10:58 am
Novartis
Pharma CEOs
vaccines
pandemic
COVID-19
Vas Narasimhan
Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like
Endpoints
Thu, 01/30/20 - 10:49 am
Novartis
China
Pharma CEOs
Vas Narasimhan
JPM: New Novartis pharma chief rethinks its drug-launch formula
Fierce Pharma
Wed, 01/15/20 - 10:49 am
Novartis
Pharma CEOs
Vas Narasimhan
drug launches
JPMHC 2020
JPM: With new ethics plan, Novartis chief puts his money where his mouth is
Fierce Pharma
Mon, 01/13/20 - 11:45 pm
Novartis
ethics
Pharma CEOs
Vas Narasimhan
JPMHC 2020
Novartis says mid-stage pipeline is setting up strong growth spurt
Pharmaforum
Thu, 12/5/19 - 10:26 am
Novartis
Pharma CEOs
Vas Narasimhan
R&D
clinical trials
Novartis Makes New Data Integrity Commitment
RAPS.org
Mon, 09/9/19 - 11:22 am
Novartis
data
data integrity
Vas Narasimhan
Zolgensma
AveXis scientific founder fires back at Novartis CEO Vas Narasimhan, 'categorically denies any wrongdoing'
Endpoints
Mon, 08/19/19 - 11:36 pm
Novartis
AveXis
Brian Kaspar
Vas Narasimhan
Zolgensma
Pages
1
2
3
next ›
last »